Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 5 September, 2025
Notification of sale of treasury shares as of September 5, 2025
Sofia, Bulgaria, September 5, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 4, 2025 the Company sold 67 700 (sixty-seven thousand seven hundred) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 184 903.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.73.
Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 4 September, 2025
Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 4 September, 2025
Notification of sale of treasury shares as of September 4, 2025
Sofia, Bulgaria, September 4, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on September 3, 2025 the Company sold 13 400 (thirteen thousand four hundred) treasury shares representing 0.002% of the share capital of the Company, at a total value of BGN 36 335.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.71.
Notification from "Sofprint Group" AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma as of 3 September,2025
Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 3 September, 2025
Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 3 September, 2025
Notification from Rositsa Doneva in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 3 September, 2025
Strony
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- następna ›
- ostatnia »